Background Well‐differentiated thyroid cancer (WDTC) recurs in up to 30% of patients.
Guidelines from the American Thyroid Association (ATA) and the National Comprehensive …

Objective To discuss the risk of recurrence in patients with differentiated thyroid cancer and
emphasize the importance of risk-group stratification. Methods Common risk factors …

Abstract This American Head and Neck Society (AHNS) consensus statement focuses on
the detection and management of recurrent thyroid cancer. This document describes the …

The significance of cervical lymph node metastases in differentiated thyroid cancer has been
controversial and continues to evolve. Current staging systems consider nodal metastases …

Simple Summary The most appropriate treatment for local/regional recurrent differentiated
thyroid cancers (DTC) is surgical excision if feasible, followed by adjuvant radioiodine …

Purpose Our purpose as to evaluate the impact of adjuvant radioactive iodine therapy (RAI)
on prognosis, as assessed by progression-free survival (PFS) and overall survival (OS), in …

Background: The primary goals of this interdisciplinary consensus statement are to define
the eligibility criteria for management of recurrent and persistent cervical nodal disease in …

Introduction: Differentiated thyroid cancer (DTC), which includes papillary and follicular, is
the most common type of thyroid cancer and the incidence is rising. Survival rates of DTC …

Occasionally in medicine a clinical situation that ap-pears simple on the surface is, in reality,
much more difficult and complex. Such is the case with the common occurrence (estimated …

Objectives: Identification of the prognostic factors relevant for long-term survival in
differentiated thyroid cancer in a homogenously treated patient cohort in order to allow a …